Equifax (NYSE:EFX) Issues FY24 Earnings Guidance

Equifax (NYSE:EFX) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $7.25-7.35 for the period, compared to the consensus estimate of $7.36. The company issued revenue guidance of $5.70-5.72 billion, compared to the consensus revenue estimate of $5.73 billion. Equifax also updated its FY 2024 guidance to 7.250-7.350 EPS.

Equifax Stock Performance

EFX stock opened at $280.30 on Friday. The firm has a 50 day moving average of $294.88 and a two-hundred day moving average of $262.80. Equifax has a 12 month low of $159.95 and a 12 month high of $309.63. The company has a market capitalization of $34.65 billion, a price-to-earnings ratio of 62.43, a P/E/G ratio of 2.00 and a beta of 1.58. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 1.01.

Equifax (NYSE:EFX) last posted its earnings results on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.01. Equifax had a return on equity of 18.88% and a net margin of 10.67%. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same period last year, the company earned $1.76 earnings per share. The business’s revenue was up 9.3% compared to the same quarter last year. As a group, equities analysts anticipate that Equifax will post 7.36 EPS for the current fiscal year.

Equifax Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Tuesday, September 3rd were paid a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend was Tuesday, September 3rd. Equifax’s payout ratio is 34.74%.

Wall Street Analyst Weigh In

EFX has been the topic of several recent analyst reports. Wolfe Research started coverage on shares of Equifax in a report on Tuesday, July 9th. They issued an “outperform” rating and a $275.00 target price on the stock. The Goldman Sachs Group upped their price target on Equifax from $277.00 to $307.00 and gave the stock a “neutral” rating in a report on Tuesday, August 20th. Oppenheimer increased their price target on shares of Equifax from $300.00 to $315.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Morgan Stanley boosted their price objective on shares of Equifax from $250.00 to $271.00 and gave the stock an “equal weight” rating in a report on Thursday, September 12th. Finally, Citigroup lifted their target price on Equifax from $263.00 to $304.00 and gave the stock a “buy” rating in a research report on Wednesday, July 24th. Four investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $307.74.

Insider Activity

In other Equifax news, EVP Carla Chaney sold 3,000 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $281.85, for a total transaction of $845,550.00. Following the transaction, the executive vice president now owns 10,875 shares of the company’s stock, valued at approximately $3,065,118.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.57% of the stock is currently owned by corporate insiders.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.